Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("HALL SW")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 29

  • Page / 2
Export

Selection :

  • and

TORNWALDT'S DISEASE. ONSET AS SYMPTOMATIC (SECONDARY) GLOSSOPHARYNGEAL NEURALGIA = MALADIE DE TORNWALDT. DEBUT PAR UNE NEVRALGIE GLOSSOPHARYNGEE SYMPTOMATIQUE SECONDAIRESTERN LZ; HALL SW.1972; NEUROLOGY; U.S.A.; DA. 1972; VOL. 22; NO 11; PP. 1182-1185; BIBL. 12REF.Serial Issue

HUMAN PHARMACOLOGY OF PRIBENICILLIN.GROSE WE; BODEY GP; HALL SW et al.1976; CURR. THERAPEUT. RES.; U.S.A.; DA. 1976; VOL. 20; NO 4 PART. 2; PP. 604-609; BIBL. 4 REF.Article

RECALL, RECOGNITION, AND RATE: MEMORY AND THE HEARTJENNINGS JR; HALL SW JR.1980; PSYCHOPHYSIOLOGY; USA; DA. 1980; VOL. 17; NO 1; PP. 37-46; BIBL. 2 P.Article

CLINICAL PHARMACOLOGY OF SYSTEMIC CHEMOTHERAPEUTIC AGENTS IN SKIN NEOPLASMSHALL SW; TI LI LOO.1978; INTERNATION. J. DERMATOL.; USA; DA. 1978; VOL. 17; NO 8; PP. 659-665; BIBL. 24 REF.Article

INTERMITTENT HIGH SINGLE-DOSE FTORAFUR: PHASE I CLINICAL TRIAL A PHARMACOLOGIC-TOXICITY CORRELATION.HALL SW; VALDIVIESO M; BENJAMIN RS et al.1977; CANCER TREATM. REP.; U.S.A.; DA. 1977; VOL. 61; NO 8; PP. 1495-1498; BIBL. 10 REF.Article

DISPOSITION AND METABOLISM OF 1-(TETRAHYDRO-2-FURANYL)-5-FLUOROURACIL (FTORAFUR) IN HUMANSBENVENUTO JA; LU K; HALL SW et al.1978; CANCER RES.; USA; DA. 1978; VOL. 38; NO 11; PP. 3867-3870; BIBL. 16 REF.Article

CLINICAL PHARMACOLOGY OF THE ANTICANCER POLYPEPTIDE NEOCARZINOSTATINHALL SW; KNIGHT J; BROUGHTON A et al.1983; CANCER CHEMOTHERAPY AND PHARMACOLOGY; ISSN 0344-5704; DEU; DA. 1983; VOL. 10; NO 3; PP. 200-204; BIBL. 17 REF.Article

DIRECT MEASUREMENT OF INTRINSIC CONDUCTIVITY OF ZNO POWDERSROPP RC; HALL SW; ROPP RJ et al.1979; AMER. CERAM. SOC. BULL.; USA; DA. 1979; VOL. 58; NO 2; PP. 197-200; BIBL. 10 REF.Article

ENZYMATIC ASSAY FOR THE ANTITUMOR AGENT N-(PHOSPHONACETYL)-L-ASPARTIC ACID (PALA)FRIEDMAN J; MOORE EC; HALL SW et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 1; PP. 85-88; BIBL. 9 REF.Article

ADRIAMYCIN, BCNU, FTORAFUR CHEMOTHERAPY OF PANCREATIC AND BILIARY TRACT CANCERHALL SW; BENJAMIN RS; MURPHY WK et al.1979; CANCER; USA; DA. 1979; VOL. 44; NO 6; PP. 2008-2013; BIBL. 19 REF.Article

CALCINOSIS IN NONPARATHYROID MALIGNANT DISEASE; AN UNUSUAL CASE REPORT AND CLINICOPATHOLOGIC REVIEW OF 17 CASES.HALL SW; LUNA MA; BEDROSSIAN C et al.1978; MED. PEDIATR. ONCOL.; U.S.A.; DA. 1978; VOL. 4; NO 1; PP. 49-58; BIBL. 12 REF.Article

BLEOMYCIN CLINICAL PHARMACOLOGY BY RADIOIMMUNOASSAYHALL SW; STRONG JE; BROUGHTON A et al.1982; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1982; VOL. 9; NO 1; PP. 22-25; BIBL. 9 REF.Article

ACTINOMYCIN-D, LEVAMISOLE CHEMOIMMUNOTHERAPY OF REFRACTORY MALIGNANT MELANOMAHALL SW; BENJAMIN RS; LEWINSKI U et al.1979; CANCER; USA; DA. 1979; VOL. 43; NO 4; PP. 1195-1200; BIBL. 13 REF.Article

CLINICAL PHARMACOLOGY OF TETRAHYDROURIDINE.HO DHW; BODEY GP; HALL SW et al.1978; J. CLIN. PHARMACOL.; U.S.A.; DA. 1978; VOL. 18; NO 5-6; PP. 259-265; BIBL. 23 REF.Article

DOXORUBICIN-DNA COMPLEX: A PHASE I CLINICAL TRIAL = COMPLEXE ADRIAMYCINE-ADN: UN ESSAI CLINIQUE PHASE IHALL SW; BENJAMIN RS; BURGESS MA et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 12; PP. 2033-2037; ABS. ENG; BIBL. 13 REF.; GRAPHArticle

KINETICS OF GALLIUM NITRATE, A NEW ANTICANCER AGENTHALL SW; YEUNG K; BENJAMIN RS et al.1979; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1979; VOL. 25; NO 1; PP. 82-87; BIBL. 16 REF.Article

PHASE I STUDY OF MAYTANSINE USING A 3-DAY SCHEDULE.CABANILLAS F; RODRIGUEZ V; HALL SW et al.1978; CANCER TREATM. REP.; U.S.A.; DA. 1978; VOL. 62; NO 3; PP. 425-428; BIBL. 3 REF.Article

THE PHARMACOKINETICS OF BLEOMYCIN IN MAN.KRAMER WG; FELDMAN S; BROUGHTON A et al.1978; J. CLIN. PHARMACOL.; USA; DA. 1978; VOL. 18; NO 7; PP. 346-352; BIBL. 15 REF.Article

METABOLISM AND DISPOSITION OF BAKER'S ANTIFOLATE (NSC-139105) FTORAFUR (NSC-148958), AND DICHLORALLYL LAWSONE (NSC-126771) IN MANTI LI LOO; BENJAMIN RS; LU K et al.1978; DRUG METABOL. REV.; USA; DA. 1978; VOL. 8; NO 1; PP. 137-150; BIBL. 5 REF.Conference Paper

PHASE 1 CLINICAL INVESTIGATION OF 4'-(9-ACRIDINYLAMINO)METHANESULFON-M-ANISIDIDE (NSC 249992), A NEW ACRIDINE DERIVATIVELEGHA SS; GUTTERMAN JU; HALL SW et al.1978; CANCER RES.; USA; DA. 1978; VOL. 38; NO 11; PP. 3712-3716; BIBL. 7 REF.Article

HYPEREOSINOPHILIC SYNDROME WITH BIVENTRICULAR INVOLVEMENT.HALL SW JR; THEOLOGIDES A; FROM AHL et al.1977; CIRCULATION; U.S.A.; DA. 1977; VOL. 55; NO 1; PP. 217-222; BIBL. 10 REF.Article

A PHARMACOKINETICALLY BASED PHASE I-II STUDY OF SINGLE-DOSE ACTINOMYCIN D(NSC-3053)BENJAMIN RS; HALL SW; BURGESS MA et al.1976; CANCER TREATM. REP.; U.S.A.; DA. 1976; VOL. 60; NO 3; PP. 289-291; BIBL. 11 REF.Article

REGRESSION OF REGIONALLY CONFINED MELANOMA WITH INTRA-ARTERIAL CIS-DICHLORODIAMMINE PLATINUM (II)PRITCHARD JD; MAVLIGIT GM; BENJAMIN RS et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 4; PP. 555-558; BIBL. 11 REF.Article

CLINICAL PHASE I-II STUDY OF CIS-DICHLORO-DIAMMINE-PLATINUM(II) GIVEN BY CONTINUOUS I.V. INFUSIONSALEM P; HALL SW; BENJAMIN RS et al.1978; CANCER TREATM. REP.; USA; DA. 1978; VOL. 62; NO 10; PP. 1553-1555; BIBL. 9 REF.Article

PHASE II STUDY OF 4'-(9-ACRIDINYLAMINO) METHANESULFON-MANISIDIDE(AMSA) IN METASTATIC MELANOMALEGHA SS; HALL SW; POWELL KC et al.1980; CANCER CLIN. TRIALS; USA; DA. 1980; VOL. 3; NO 2; PP. 111-114; BIBL. 6 REF.Article

  • Page / 2